Point-of-care testing for the analysis of lipid panels: Primary care diagnostic technology update

British Journal of General Practice

Volumn 62, Issue 596, 2012, Pages

  Plüddemann, Annette ^a   Thompson, Matthew ^a   Price, Christopher P ^a   Wolstenholme, Jane ^a   Heneghan, Carl ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KETONE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACCURACY; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; HOSPITAL INFORMATION SYSTEM; HUMAN; LIPID ANALYSIS; LONG TERM CARE; PATIENT CARE; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; RISK ASSESSMENT; SHORT SURVEY; STANDARD;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL; COST-BENEFIT ANALYSIS; HUMANS; HYPERCHOLESTEROLEMIA; MIDDLE AGED; POINT-OF-CARE SYSTEMS; REAGENT KITS, DIAGNOSTIC; RISK ASSESSMENT; TRIGLYCERIDES;

EID: 84857777622     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp12X630241     Document Type: Short Survey

References (12)

1. Centre for Evidence Based Purchasing.CEP catalogue search. London: Department of Health, 2010. http://nhscep.useconnect.co.uk/CEPProducts /Catalogue.aspx?ReportType=Buyers%27+gui de (accessed 7 Feb 2012).
2. Parikh P, Mochari H, Mosca L. Clinical utility of a fingerstick technology to identify individuals with abnormal blood lipids and high-sensitivity C-reactive protein levels. Am J Health Promot 2009; 23(4): 279-282.
3. Carey M, MarkhamC, Gaffney P, et al. Validation of a point of care lipid analyser using a hospital based reference laboratory. Ir J Med Sci 2006; 175(4): 30-35. (Pubitemid 46218035)
4. Stein JH, Carlsson CM, Papcke-Benson K, et al. Inaccuracy of lipidmeasurements with the portable Cholestech LDX analyzer in patients with hypercholesterolemia.Clin Chem 2002; 48(2): 284-290. (Pubitemid 34107265)
5. Dale RA, Jensen LH, Krantz MJ. Comparison of two point-of-care lipid analyzers for use in global cardiovascular risk assessments. Ann Pharmacother 2008; 42(5): 633-639. (Pubitemid 351619933)
6. Shephard MD, Mazzachi BC, Shephard AK. Comparative performance of two point-ofcare analysers for lipid testing.Clin Lab 2007; 53(9-12): 561-566. (Pubitemid 351165867)
7. Bubner TK, Laurence CO, Gialamas A, et al. Effectiveness of point-of-care testing for therapeutic control of chronic conditions: results fromthe PoCT in General Practice Trial.Med J Aust 2009; 190(11): 624-626.
8. Gialamas A, Yelland LN, Ryan P, et al. Does point-of-care testing lead to the same or better adherence tomedication? A randomised controlled trial: the PoCT in General Practice Trial.Med J Aust 2009; 191(9): 487-491.
9. Cohen J, Piterman L, McCall LM, et al. Nearpatient testing for serumcholesterol: attitudes of general practitioners and patients, appropriateness, and costs.Med J Aust 1998; 168(12): 605-609. (Pubitemid 28288618)
10. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med 2002; 162(10): 1149-1155. (Pubitemid 34522403)
11. Laurence CO, Moss JR, Briggs NE, et al. The cost-effectiveness of point of care testing in a general practice setting: results froma randomised controlled trial.BMC Health Serv Res 2010; 10: 165.
12. Taylor JR, Lopez LM. Cholesterol: point-ofcare testing. Ann Pharmacother 2004; 38(7-8): 1252-1257.